Metastatic Large-cell Neuroendocrine Carcinoma
2 clinical trials · Condition
◉ Watch Metastatic Large-cell Neuroendocrine Carcinoma
| Record | Firm | Date |
|---|---|---|
| Enasidenib in IDH2-Mutated Malignant Sinonasal and Skull Base Tumors (NCT06176989) | National Cancer Institute (NCI) | 2024-03-04 |
| Testing the Combination of XL184 (Cabozantinib), Nivolumab, and Ipilimumab for Poorly Differentiated Neuroendocrine Tumors (NCT04079712) | National Cancer Institute (NCI) | 2020-08-06 |
Track Metastatic Large-cell Neuroendocrine Carcinoma automatically
Every clearance here is in the API, with alerts when new ones post.